Skip to content
ApprovedFDA approvedModerate evidence

Gabapentin

Prescription medicine for seizures and nerve pain, also used off-label for anxiety; it can cause dependence.

AnxiolyticGabapentinoidAnticonvulsantGabapentinoidAnxiolyticGABAGlutamate
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassGabapentinoid · Anxiolytic
Primary targetα2δ-1 calcium channel subunit
Targets3 receptor targets
Half-life5-7 hours, cleared largely unchanged by the kidneys
Onset1-3 hours to peak plasma; sedating and anxiolytic effects within a few hours
EvidenceModerate evidence
Affected systemsGABAGlutamate

Contents

DETAILED OVERVIEW

What is Gabapentin?

Gabapentin (Neurontin) is a prescription medicine originally developed to prevent seizures. In the European Union, including Hungary, it is approved for epilepsy and nerve-related pain, and it is also used off-label for anxiety and sleep problems.

Despite its name and its structural similarity to GABA, it does not act on GABA receptors: it binds to certain calcium channels of nerve cells and so reduces the release of exciting messengers such as glutamate. In placebo-controlled studies it eased the symptoms of social anxiety and of more severe panic disorder; the evidence for generalized anxiety is weaker. It can cause drowsiness and dizziness, and stopping it suddenly can cause withdrawal symptoms such as anxiety, sleeplessness and sweating. It has a real potential for dependence and misuse, so it is a controlled drug in the United Kingdom and in several US states. Together with opioids or other sedating drugs it can cause life-threatening slowing of breathing.

Mechanism

α2δ-1 calcium channel binder

Half-life

5-7 hours (renally cleared)

Legal status

Prescription (Rx), off-label for anxiety

Receptor profile

  • α2δ-1 calcium channel subunitStrong
  • Presynaptic voltage-gated calcium channelsStrong
  • Excitatory neurotransmitter release (glutamate, substance P)Moderate

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Drowsiness, sedation and fatigue, especially early in treatment
  • Dizziness and coordination problems (ataxia), fall risk in the elderly
  • Peripheral edema (limb swelling) and weight gain
  • Withdrawal on abrupt cessation: anxiety, insomnia, sweating
  • Life-threatening respiratory depression when combined with opioids or other CNS depressants
  • Genuine misuse and dependence potential, especially with a history of substance use disorder

Contraindications · 5

  • Renal impairment: the drug is cleared unchanged by the kidneys, dose adjustment required
  • Concurrent opioids or CNS depressants: increased respiratory depression (FDA warning)
  • History of substance use disorder: caution due to misuse risk
  • Avoid abrupt discontinuation: gradual taper required
  • Pregnancy and breastfeeding: only if benefit outweighs risk

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Gabapentin is a prescription medication originally developed as an anticonvulsant, most commonly used today for nerve-related pain, but also used off-label, meaning outside its official approved use, for anxiety and sleep problems. In studies it reduced symptoms of social anxiety and panic disorder, helped with pre-surgery nervousness, and eased anxiety and insomnia during alcohol withdrawal. It's important to note this is a prescription drug requiring medical supervision, not a freely available nootropic.

Telegram

Have a question about Gabapentin?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAnxiolytic
FormulaC9H17NO2
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.